Riskpilot← Back to searchSign inGet full accessMARITOPPEN INVEST AS
ASActiveOrg 988979074Nilserudkleiva 17, 0874 OsloActivities of trust, estate and agency accounts · NACE 6432Est. 20060 employees
Revenue 2024
NOK 0
EBITDA margin
—
-10% vs 2023
Equity ratio
99.8%
Financial strength
Net profit 2024
NOK 23,8M
+2203% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -672K | -10% |
| Net profit | NOK 23,8M | +2203% |
| Total assets | NOK 157,2M | +13% |
| Equity | NOK 156,9M | +13% |
| Employees | 0 | — |
Legal name
MARITOPPEN INVEST AS
Org number
988979074
Legal form
Aksjeselskap
NACE code
6432 · Activities of trust, estate and agency accounts
Founded
17. januar 2006
Share capital
NOK 1 036 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder og ett styremedlem i fellesskap.
Company purpose
Investering i andre selskaper, aksjer, verdipapirer, fast eiendom og alminnelig investeringsvirksomhet, herunder også deltakelse i andre selskaper med tilsvarende eller beslektet formål.
Address
Nilserudkleiva 17, 0874 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −536 | −666 | −593 | −612 | −672 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −536 | −666 | −593 | −612 | −672 |
| Net financials | 6 937 | 27 022 | 525 | 1 644 | 24 719 |
| Profit before tax | 6 401 | 26 356 | −68 | 1 032 | 24 047 |
| Tax | 348 | 375 | −0 | −0 | 284 |
| Net profit | 6 053 | 25 981 | −68 | 1 032 | 23 763 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 135 127 | 152 988 | 144 399 | 139 356 | 157 187 |
| Equity | 126 632 | 144 467 | 138 323 | 139 355 | 156 902 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 8 495 | 8 522 | 6 075 | 1 | 285 |
| Total debt | 8 495 | 8 522 | 6 075 | 1 | 285 |
EBITDA margin
-67218700.0%
This company
15.8%
Market median
-425434910% vs market
20202024
Equity ratio
99.8%
This company
38.2%
Market median
+161% vs market
20202024
Return on equity
15.1%
This company
18.4%
Market median
+18% vs market
20202024
Net profit margin
2376292600.0%
This company
8.1%
Market median
+29336945579% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2020 | |
| Board of Directors | 2020 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Halvor Weider | Company | 10.01% | 10.01% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
MARITOPPEN INVEST AS (this company)
Palla Pharma Norway Holding AsBoard members of MARITOPPEN INVEST AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Britt Gunvor Weider | Board of Directors | 0 companies |
| Kari Louise Weider Brende | Board of Directors | 0 companies |